Function of novel proteins encoded in non-canonical open reading frames
Function of novel proteins encoded in non-canonical open reading frames
批准号:
RGPIN-2021-03723
负责人:
Vanderperre, Benoît
金额:
$2.7万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31
中文摘要
蛋白质基本上是所有细胞过程中的关键角色,在这些过程中它们发挥着过多的功能(例如,化学反应的催化、分子的运输)。了解这些功能会让我们了解我们的细胞、器官和身体的工作方式。几十年来,人们一直认为每个真核基因只编码一种蛋白质。然而,过去几年的许多研究挑战了这一观点,现在很明显,许多基因实际上编码多种蛋白质。这些以前未知和被忽视的新蛋白质,不同于众所周知的蛋白质异构体,被称为替代蛋白质,并在我们的细胞中平行表达那些已鉴定的蛋白质(称为参考蛋白质),极大地扩展了蛋白质谱。尽管少数替代蛋白质的特性揭示了重要的生物学功能,但全世界只有少数几个研究小组在他们的工作中考虑到它们的存在。考虑到他们最近的发现,替代蛋白质在很大程度上仍然没有得到充分的研究,而且还没有出现在常用的功能基因组学工具中。我的研究计划的长期目标是通过研究特定的例子(候选方法)和使用功能基因组学(全基因组方法)来阐明替代蛋白质的分子、细胞和组织功能。在目前的发现计划中,我们将专注于以下短期目标:1.确定SLC35A4的分子、细胞和组织功能,SLC35A4是一个编码两种蛋白质的基因,其中包括一种含量惊人但尚未确定的替代蛋白,可能与髓鞘有关,髓鞘是传递信息所需的神经系统组成部分。这将使用培养细胞(包括人类诱导的多能干细胞)和小鼠模型,结合生化、细胞生物学和多组学方法来实现。2.创建用于全基因组CRISPR/Cas9筛选的功能基因组学工具,以大规模发现替代蛋白质的功能,并使用多组学方法在更广泛的细胞景观中机械地表征功能替代蛋白质。我们对候选基因功能的发现(目标1)将为脊椎动物中这种丰富的替代蛋白提供第一个深入的表征。所建立的细胞和小鼠模型将对其他研究小组研究这种双重编码基因(例如。在髓鞘形成领域)。目标1将举例说明研究替代蛋白和参考蛋白的必要性,以充分了解我们基因的功能。此外,目标2将大大加快研究人员大规模研究替代蛋白质功能的能力。这些新的和开放的功能基因组学工具整合了替代蛋白质,将极大地帮助我们加深对替代蛋白质对我们基因功能的贡献的了解,并将使加拿大处于这一新领域的前沿。
英文摘要
Proteins are key players in basically all cellular processes, where they exert a plethora of functions (e.g. catalysis of chemical reactions, transport of molecules). Understanding these functions informs us on the way our cells, organs and bodies work. For decades, it was thought that only one protein was encoded per eukaryotic gene. However, many studies in the past few years have challenged that view, and it is now evident that many genes actually encode multiple proteins. These previously unknown and ignored novel proteins, which are different from well-known protein isoforms, are called alternative proteins and are expressed in our cells in parallel to those already identified (called reference proteins), greatly expanding the protein repertoire. Despite the characterization of a small number of alternative proteins which revealed important biological functions, only a few research groups worldwide consider their existence in their work. Given their recent discovery, alternative proteins remain largely understudied, and are absent from commonly used functional genomics tools. The long-term objective of my research program is to elucidate the molecular, cellular, and organismal functions of alternative proteins, by studying specific examples (candidate approach) and using functional genomics (genome-wide approach). In the present Discovery proposal, we will focus on the following short-term objectives: 1. Determine the molecular, cellular and organismal function of SLC35A4, a gene encoding two proteins, including a strikingly abundant but uncharacterized alternative protein with possible ties to myelin, a nervous system component needed for transit of information. This will be achieved using cultured cells (including human induced pluripotent stem cells) and mouse models, coupled to biochemical, cell biology and multi-omics methods. 2. Create functional genomics tools for genome-wide CRISPR/Cas9 screening to discover the function of alternative proteins at a large scale, and use multi-omics methods to mechanistically characterize functional alternative proteins within the broader cellular landscape. Our findings on the function of our candidate gene (Objective 1) will provide the first deep characterization of this abundant alternative proteins in vertebrates. The cellular and mouse models created will be of interest for other groups to study this dual coding gene (for ex. in the myelination field). Objective 1 will exemplify the necessity of studying both alternative and reference proteins to fully understand the functions of our genes. In addition Objective 2 will significantly accelerate the researchers' ability to study the function of alternative proteins at a large scale. These novel and open functional genomics tools that integrate alternative proteins will significantly help advancing our knowledge of the contribution of alternative proteins to the function of our genes, and will place Canada at the forefront of this new field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Function of novel proteins encoded in non-canonical open reading frames
-
批准号:RGPAS-2021-00005
-
项目类别:Discovery Grants Program - Accelerator Supplements
-
资助金额:$2.91万
-
财政年份:2022
-
负责人:Vanderperre, Benoît
-
依托单位:
Function of novel proteins encoded in non-canonical open reading frames
-
批准号:RGPIN-2021-03723
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.7万
-
财政年份:2022
-
负责人:Vanderperre, Benoît
-
依托单位:
Function of novel proteins encoded in non-canonical open reading frames
-
批准号:RGPAS-2021-00005
-
项目类别:Discovery Grants Program - Accelerator Supplements
-
资助金额:$2.91万
-
财政年份:2021
-
负责人:Vanderperre, Benoît
-
依托单位:
Function of novel proteins encoded in non-canonical open reading frames
-
批准号:DGECR-2021-00199
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2021
-
负责人:Vanderperre, Benoît
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
-
批准号:32402377
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:戴恬美
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位: